LYRA - Lyra Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $15.51. This is a potential upside of $7.84 (102.22%) from yesterday's end of day stock price of $7.67.

Lyra Therapeutics 's activity chart (see below) currently has 0 price targets and 1 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 78.57% with an average time for these price targets to be met of 575.17 days.

Highest price target for LYRA is $16, Lowest price target is $16, average price target is $16.

Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 14-Aug-2025. First documented stock forecast 26-May-2020.

Best performing analysts who are covering LYRA - Lyra Therapeutics :

Jason Gerberry Matthew Caufield Robert Hazlett Louise Chen Dennis Ding Justin Zelin

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$16

$9.53 (147.30%)

$16

1 months 26 days ago
(14-Aug-2025)

5/7 (71.43%)

$8.9 (125.35%)

422

Buy

1 years 1 months 25 days ago
(15-Aug-2024)

1/1 (100%)

$9 (150.00%)

1105

Hold

$0.5

$-5.97 (-92.27%)

1 years 5 months 3 days ago
(07-May-2024)

1/1 (100%)

$0.08 (19.05%)

386

Hold

$15

1 years 5 months 4 days ago
(06-May-2024)

1/1 (100%)

$11.36 (312.09%)

605

Buy

$10

$3.53 (54.56%)

$11

1 years 5 months 8 days ago
(02-May-2024)

6/6 (100%)

$5.37 (115.98%)

933

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LYRA (Lyra Therapeutics ) average time for price targets to be met?

On average it took 575.17 days on average for the stock forecasts to be realized with a an average price target met ratio 78.57

Which analyst has the current highest performing score on LYRA (Lyra Therapeutics ) with a proven track record?

JASON GERBERRY

Which analyst has the current lower performing score on LYRA (Lyra Therapeutics ) with a proven track record?

JUSTIN ZELIN

Which analyst has the most public recommendations on LYRA (Lyra Therapeutics )?

Jason Gerberry works at BAML and has 0 price targets and 0 ratings on LYRA

Which analyst is the currently most bullish on LYRA (Lyra Therapeutics )?

Matthew Caufield with highest potential upside - $9.53

Which analyst is the currently most reserved on LYRA (Lyra Therapeutics )?

Dennis Ding with lowest potential downside - -$5.97

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?